{
  "docId": "019de074-f3a0-71ae-8e30-38333965b689",
  "docSlug": "e090e5c29fca7648cb88dae8fea2c1eb",
  "documentTitle": "Kiromic BioPharma | Investor Presentation Deck | 25 slides",
  "authorId": "kiromic-biopharma",
  "authorName": "Kiromic BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 4,
  "pageCount": 25,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "unfair_advantage",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide uses a hexagonal grid layout to highlight five core pillars of their competitive advantage.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-f3a0-71ae-8e30-38333965b689/4",
  "deckHref": "/decks/019de074-f3a0-71ae-8e30-38333965b689",
  "deckJsonHref": "/decks/019de074-f3a0-71ae-8e30-38333965b689.json",
  "deckAnchorHref": "/decks/019de074-f3a0-71ae-8e30-38333965b689#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.35,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Hexagonal grid of five key pillars: Diamond AI, Allogeneic Therapy, GDT Platform, Solid Malignancies, In-House Manufacturing",
      "attrs": null,
      "subkind": "other",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b471d03-476a-4a23-b60d-a852167e7ef8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.5,
        "y": 0.7
      },
      "kind": "metric",
      "text": "~90% of all cancers",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4918b1d3-4647-4636-a39c-096619b95e74",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.28,
        "x": 0.02,
        "y": 0.315
      },
      "kind": "paragraph",
      "text": "Kiromic BioPharma is the only cell therapy company combining AI-driven genetically edited Gamma Delta T-cells (GDT) with proprietary targeting technology to address solid malignancies.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b597e353-b1d2-411b-89dc-1b26cb705a38",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.02,
        "y": 0.15
      },
      "kind": "title",
      "text": "The Kiromic Difference",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8537ac1a-c638-48c7-8961-7da2e0b6b49d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}